/
PHRRF
$0.04+$0.00 (+0.57%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.03 – $0.55
1% from low
Exchange
OTC Link
OS
Price (6 mo)
Loading chart…
Change$-0.24
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $0 | $355 | $1.8K | $1.4K | $0 | $0 |
| Gross profit | $0 | −$355 | −$1.8K | −$1.4K | $0 | $0 |
| Gross margin | — | — | — | — | — | — |
| R&D | $0 | $751.5K | $2.6M | $3.0M | $2.1M | $581.6K |
| Operating income | −$23.8K | −$2.4M | −$4.0M | −$4.0M | −$3.0M | −$1.5M |
| EBITDA | $0 | −$2.4M | −$4.0M | −$4.0M | −$3.0M | −$1.5M |
| Net income | −$23.8K | $2.7M | −$4.0M | −$6.4M | −$3.1M | −$1.5M |
| Net margin | — | — | — | — | — | — |
| EPS (diluted) | -0.00 | 0.04 | -0.05 | -0.07 | -0.04 | -0.02 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2027 | $81M | $-0.04 | $-0.04–$-0.04 | 1 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$0.00
Price
$0.04
Implied downside
-87%
Peer comparison
PHARMATHER HLDGS LTD
PHARMATHER HLDGS LTD
Held by traders on TradeandTell
No one on the platform currently holds PHRRF.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in PHRRF as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded PHRRF yet.
